Aviptadil is a vasoactive pulmonary artery (VIP) analogue with strong vasodilatory effects. Aviptadil induces pulmonary vasodilation and inhibits vascular SMCs ischemia and ischemia. Aviptadil can be used in the study of pulmonary fibrosis, pulmonary arterial hypertension (PAH), and respiratory ischemia caused by SARS-CoV-2.
It is also a vasoactive intestinal peptide (VIP) analogue with strong vasodilatory effects. Aviptadil induces pulmonary vasodilation, inhibits the proliferation of vascular SMCs and platelet aggregation. Aviptadil can be used for research on pulmonary fibrosis, pulmonary arterial hypertension (PAH), respiratory failure caused by SARS-CoV-2, etc. Aviptadil is a peptide composed of 29 amino acids.
